Boston Scientific Said to Abandon Sale of Pain Unit

Lock
This article is for subscribers only.

Boston Scientific Corp. has halted efforts to sell its pain-management business after disagreements over the value of the unit, said four people familiar with the matter.

Boston Scientific, based in Natick, Massachusetts, tried for several months to sell its neuromodulation business and was seeking from $1.5 billion to $2 billion for it, said the people, who declined to be named because the talks were private. Boston Scientific halted the process a few weeks ago and is unlikely to pursue a sale of the unit, one person said.